Peripheral signals, central questions: Examining the relationship between psychedelics and brain-derived neurotrophic factor (BDNF)
Vivek Seelamneni
Psychedelics April 10, 2024 DOI: 10.61373/pp024c.0013 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Commentary Peer reviewed |
|---|---|
| Citations | 1 |
| Key points | Highlights a meta-analysis reporting the effect of psychedelics on peripheral BDNF levels. |
Abstract
What are the mechanisms through which psychedelics may exert therapeutic effects in psychiatric disorders? There are two approaches to answering this question: first is the identification of novel pathways. Additionally, it would be of interest to determine the effects of psychedelics on mechanisms that already appear to underlie the neurobiology and therapeutics of psychiatric disorders. This commentary highlights a recent article by Shafiee et al. (1) that reported a meta-analysis of the effect of psychedelics on the peripheral levels of brain-derived neurotrophic factor (BDNF).
Citations in the library
Cites 3
- Role of BDNF in the pathophysiology and treatment of depression: Activity‐dependent effects distinguish rapid‐acting antidepressants European Journal of Neuroscience December 6, 2019
- Australia to prescribe MDMA and psilocybin for PTSD and depression in world first Nature July 13, 2023
- The effect of psychedelics on the level of brain-derived neurotrophic factor: A systematic review and meta-analysis. Journal of Psychopharmacology May 1, 2024